Effect of mexiletine on lipid peroxidation and early ultrastructural findings in experimental spinal cord injury

Journal of Neurosurgery

Volumn 91, Issue SUPPL. 2, 1999, Pages 200-204

  Kaptanoglu, Erkan ^b   Caner, Hakan H ^a   Selcuk Surucu H ^b   Akbiyik, Filiz ^b  

^a Baskent Universitesi Ankara Hastanesi   (Turkey)

^b NONE

Author keywords

Free radical; Lipid peroxidation; Methylprednisolone; Mexiletine; Spinal cord injury

Indexed keywords

LIPID PEROXIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; MEXILETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

EID: 0033500846     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/spi.1999.91.2.0200     Document Type: Article

References (28)

1. Allen AR: Surgery of experimental lesion of spinal cord equivalent to crush injury or fracture dislocation of spinal column. A preliminary report. JAMA 57:878-880, 1911
2. Anderson DK, Demediuk P, Saunders RD, et al: Spinal cord injury and protection. Ann Emerg Med 14:816-821, 1985
3. Anderson DK, Dugan LL, Means ED, et al: Methylprednisolone and membrane properties of primary cultures of mouse spinal cord. Brain Res 637:119-125, 1994
4. Anderson DK, Hall ED: Pathophysiology of spinal cord trauma. Ann Emerg Med 22:987-992, 1993
5. Benzel EC, Tator CH: Contemporary management of spinal cord injury, in Young W, Huang PP, Kume-Kick J (eds): Cellular, Ionic, and Biomolecular Mechanisms of the Injury Process. Park Ridge, Illinois: American Association of Neurosurgeons, 1995, pp 27-42
6. +)-ATPase lipid peroxidation, and alpha motor neuron function. J Neurosurg 56:838-844, 1982
7. Choi DW: Ionic dependence of glutamate neurotoxicity. J Neurosci 7:369-379, 1987
8. Demirpençe D, Caner H, Bavbek M, et al: Antioxidant action of antiaritmic drug mexiletine in brain membrane. Jpn J Pharmacol (in press, 1999)
9. Dohi Y, Kojima M, Sato K: Vasorelaxant effect of mexiletine in mesenteric resistance arteries of rats. Br J Pharmacol 111:673-680, 1994
10. Fehlings MG, Tator CH, Linden RD: The relationships among the severity of spinal cord injury, motor and somatosensory evoked potentials and spinal cord blood flow. Electroencephalogr Clin Neurophysiol 74:241-259, 1989
11. Fercakova A, Halat G, Marsala M, et al: Graded postischemic reoxygenation reduces lipid peroxidation and reperfusion injury in the rabbit spinal cord. Brain Res 593:159-167, 1992
12. Hall ED: The neuroprotective pharmacology of methylprednisolone. J Neurosurg 76:13-22, 1992
13. +)-ATPase activity: Dose response analysis during 1 hour after contusion injury in the cat. J Neurosurg 57:247-253, 1982
14. Kirkali Z, Esen AA, Hayran M, et al: The effect of extracorporeal electromagnetic shock waves on the morphology and contractility of the rabbit ureter. J Urol 154:1939-1943, 1995
15. Koreh K, Seligman ML, Ramm ES, et al: Lipid antioxidant properties of naloxone in vitro. Biochem Biophys Res Commun 102:1317-1322, 1981
16. Mihara M, Uchiyama M: Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86: 271-278, 1978
17. Monk JP, Brogden RN: Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs 40:374-411, 1990
18. Nagasako S, Hayashibara M, Katagiri Y, et al: Salivary excretion of mexiletine after bolus intravenous administration in rats. J Pharm Pharmacol 44:55-57, 1992
19. Paroczai M, Roth E, Karpati E: Bisaramil and antiarrhythmics as inhibitors of free radical generation. Pharmacol Res 35: 279-285, 1997
20. Pryor WA, Stanley JP, Blair E: Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA-reactive materials from prostaglandin-like endoperoxides. Lipids 11:370-379, 1976
21. Saunders RD, Dugan LL, Demediuk P, et al: Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J Neurochem 49:24-31, 1987
22. Shirayama T, Inoue D, Inoue M, et al: Electrophysiological effects of sodium channel blockers on the guinea pig left atrium. J Pharmacol Exp Ther 259:884-893, 1991
23. Tasdemir O, Katircioglu SF, Küçükaksu DS, et al: Warm blood cardioplegia: ultrastructural and hemodynamic study. Ann Thorac Surg 56:305-311, 1993
24. Tator CH, Fehlings MG: Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15-26, 1991
25. Tymianski M, Tator CH: Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38: 1176-1195, 1996
26. Vaughan Williams EM: A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129-147, 1984
27. Wallace MC, Tator CH: Failure of blood transfusion or naloxone to improve clinical recovery after experimental spinal cord injury. Neurosurgery 19:489-494, 1986
28. Young W: The post-injury responses in trauma and ischemia: secondary injury or protective mechanisms? Cent Nerv Syst Trauma 4:27-51, 1987